February 16, 2022

Case Western Reserve University selects Cubresa’s NuPET™ System to Support Preclinical Research Activities

Wednesday, February 16th, 2022 PRESS RELEASE Case Western Reserve University selects Cubresa’s NuPET™ System to Support Preclinical Research Activities Winnipeg, MB – February 16th, 2022 – Case Western Reserve University (CWRU) has selected Cubresa’s Preclinical NuPET™ Insert System to add to their suite of imaging tools. The NuPET 66 will support research in a wide…

Read More >

January 5, 2022

Barrow Neurological Institute selects Cubresa’s BrainPET system to support neurological research activities

Barrow Neurological Institute selects Cubresa’s BrainPET system to support neurological research activities Winnipeg, MB – January 5th, 2022 – Barrow Neurological Institute, the world’s largest neurological disease treatment and research institution, in conjunction with Arizona State University (ASU), have selected Cubresa’s BrainPET system to add to their suite of imaging tools. A joint acquisition between Barrow…

Read More >

October 20, 2021

Cubresa Enters into BrainPET Technology License Agreement with the Sino Canadian Health Institute

Wednesday, October 20th, 2021 PRESS RELEASE Cubresa Enters into BrainPET Technology License Agreement with the Sino Canadian Health Institute Winnipeg, MB – October 20th, 2021 – Cubresa Inc., a world leader in the design and development of PET Insert systems for MRI, and the Sino Canadian Health Institute (SCHI), a Canadian based wholly owned subsidiary of…

Read More >

September 20, 2021

Cubresa enters into Memorandum of Understanding with the University of California, Davis

Monday, September 20, 2021 PRESS RELEASE Cubresa enters into Memorandum of Understanding with the University of California, Davis Winnipeg, MB – September 20th, 2021 – Cubresa Inc., a world leader in the design and development of PET insert systems for MRI, has entered into a Memorandum of Understanding (MOU) with the University of California, Davis. The MOU provides a mechanism to identify and potentially pursue specific technical and application-focused research projects related to Alzheimer’s Disease…

Read More >

November 2, 2020

Cubresa’s NuPET Bio Selected By Innovative Solutions Canada

Tuesday, November 2nd, 2020 PRESS RELEASE NuPET Bio BSL3 Imaging System Selected by Innovative Solutions Canada to test in COVID-19 Research Program Winnipeg, MB – Cubresa Inc. is pleased to announce that its NuPET Bio imaging system, the first in the world specifically designed for infectious disease research in BSL3 environments, has received a contract…

Read More >

June 11, 2020

Dotmed Health Care Business News Magazine article

Cubresa is pleased to be featured in Dotmed’s Health Care Business News Magazine – June 2020 edition. The article, found on page 56, focuses on innovation in the PET and SPECT markets. Dr. James Schellenberg, Cubresa’s Founder and CEO is pleased to share information highlighting the value of its NuPET preclinical insert for SARS-CoV-2 research…

Read More >

October 23, 2019

Cubresa Marks First Preclinical NuPET™ System Sale in China

Cubresa Inc., a world leader in PET inserts for MRI, is pleased to announce that the Sino-Canadian Health Engineering Research Institute (SCHERI) of Hefei, Anhui province, China, has purchased Cubresa’s preclinical NuPET6620™ scanner. This marks Cubresa’s first sale of its NuPET system into the Chinese marketplace. “Cubresa’s NuPET6620 system is an integral component of a…

Read More >

September 3, 2019

Cubresa Introduces New PET Insert for Medium and Large Animal Imaging

Cubresa Inc., a world leader in PET inserts for MRI, is expanding its preclinical NuPET™ product line to include a large-bore insert for medium and large animal imaging. The company’s new insert system is designed for use in clinical MRI and PET/MRI systems and will accommodate non-human primates (NHP), rabbits, pigs and other animals. In…

Read More >

June 25, 2019

UWinnipeg Magazine Article

Cubresa is proud to share UWinnipeg Magazine’s article, “Searching For a Cure”, featuring Cubresa System Scientist, Dr. Sheryl Herrera. Learn more about the important industry work Dr. Herrera is undertaking at Cubresa thanks to her supervisor, Dr. Melanie Martin, and the Mitacs Elevate postdoctoral fellowship. The article can be found on page 18. UWinnipeg Article

Read More >